KBI Biopharma Capacity Update May 2024: Large Molecule Development

Discover how KBI Biopharma's development and platform-based manufacturing solutions, along with large-scale global manufacturing capacity can create an unobstructed path to market for your large molecule pipeline in a dynamic regulatory environment. As the biopharmaceutical industry faces evolving legislative landscapes and manufacturing capacity demands, KBI Biopharma stands at the forefront of offering efficient, dependable, and scalable solutions for clinical and commercial biotherapeutics. Founded on analytical services, KBI Biopharma has expanded since 2010 to encompass cell line development, process development, analytical development, manufacturing, and fill-finish solutions. Join our expert-led capacity update webinar hosted by Leslie Wolfe, PhD., VP of Process Development and Site Head at KBI Biopharma, to explore how we ensure seamless biologics development and manufacturing continuity in the US and Europe.